The FDA has posted draft guidance that, once final, will explain the agency’s intent to exercise enforcement discretion with respect to the sale and distribution of certain N-acetyl-L-cysteine (NAC)-containing products that are labeled as dietary supplements. This enforcement discretion would apply to products that would be lawfully marketed dietary supplements if NAC were not... Read More